ID
44442
Description
This CRF is set up in modules to be used for recording data on the ISARIC COVID-19 Core Database or for independent studies. Module 1 and Module 2 complete on the first day of presentation/admission or on first day of COVID-19 assessment. Module 2 also complete on first day of admission to ICU or high dependency unit. In addition, complete daily for as many days as resources allow up to a maximum of 14 days. Continue to follow-up patients who transfer between wards. Module 3 (Outcome) complete at discharge or death General Guidance: - The CRF is designed to collect data obtained through examination, interview and review of hospital notes. Data may be collected retrospectively if the patient is enrolled after the admission date. - For more detailed guidance on how to complete these forms, please refer to the CRF Completion Guideline - Participant Identification Numbers consist of a 3 digit site code and a 4 digit participant number. You can obtain a site code and registering on the data management system by contacting ISARIC. Participant numbers should be assigned sequentially for each site beginning with 0001. In the case of a single site recruiting participants on different wards, or where it is otherwise difficult to assign sequential numbers, it is acceptable to assign numbers in blocks or incorporating alpha characters. E.g. Ward X will assign numbers from 0001 or A001 onwards and Ward Y will assign numbers from 5001 or B001 onwards. Enter the Participant Identification Number at the top of every page. - Printed paper CRFs may be used for later transfer of the data onto the electronic database. - For participants who return for re-admission to the same site, start a new form with a different Participant Identification Number. Please check “YES-admitted previously” in the ONSET & ADMISSION section. Enter as 2 separate entries in the electronic database. - For participants who transfer between two sites that are both collecting data on this form, it is preferred to have the data entered by a single site as a single admission, under the same Participant Identification Number. When this is not possible, the first site should record “Transfer to other facility” as an OUTCOME, and the second site should start a new form with a new patient number and indicate “YES-transferred” in ONSET & ADMISSION. - Complete every line of every section, except for where the instructions say to skip a section based on certain responses. - Mark ‘Not done’ for any results of laboratory values that are not available, not applicable or unknown. - Avoid recording data outside of the dedicated areas. Sections are available for recording additional information. - If using paper CRFs, we recommend writing clearly in ink, using BLOCK-CAPITAL LETTERS. - Place an (X) when you choose the corresponding answer. To make corrections, strike through (-------) the data you wish to delete and write the correct data above it. Please initial and date all corrections. - Please keep all of the sheets for a single participant together e.g. with a staple or participant-unique folder. - ISARIC would like the centers to enter data directly into their electronic data capture system. Please contact ISARIC about access. If your site would like to collect data independently, ISARIC can support you in the estabilishment of locally hosted databases. This version may serve as a basis for locally hosted databases. - Please contact ISARIC, if you need help with databases, have comments or to let ISARIC know that you are using the CRF. - Please let us know if you find any mistakes in the MDM Portal's version. FURTHER GUIDANCE AND DEFINITIONS (from the Completion guideline) Comorbidities: Comorbidities present before the onset of COVID-19 and are still present. Do not include those that developed following the onset of COVID-19 symptoms. More detailed guidance is provided. Hospital admission: For patients who were admitted to hospital with COVID-19 or symptoms consistent with possible COVID-19 infection, please enter details for the date of hospital admission. For patients with a clear alternative diagnosis leading to admission who subsequently acquired COVID-19, original admission date should be provided, but all subsequent references to admission should be taken as referring to day COVID-19 was first clinically suspected (or within the first 24 hours after first day of suspected or confirmed COVID-19 infection). Where a patient was admitted via multiple hospital departments, count admission from the time they came to the first department during the visit that led to their admission (e.g. arrival at the Emergency Department). Oxygen therapy: Include any form of supplemental oxygen received using any methods. Invasive ventilation: Please include any mechanical ventilation delivered following intubation or via a tracheostomy. Do not include patients who are breathing independently via a tracheostomy. Non-invasive ventilation: Please include any positive-pressure treatment given via a tight-fitted mask. This can be continuous positive pressure (CPAP) or bi-level positive pressure (BIPAP). Renal replacement therapy or dialysis: Please include any form of continuous renal replacement therapy or intermittent haemodialysis. Worst result: References to ‘worst result’ refer to those furthest from the normal physiological range or laboratory normal range. Results that were rejected by the clinical team (e.g. pulse oximetry on poorly perfused extremities, haemolysed blood samples, contaminated microbiology results) should not be reported. The following measures should be considered as a single observation and entered together: Blood gas results: Please report the measures from the blood gas with the lowest pH (most acidotic). Blood pressure: Please report the systolic and diastolic blood pressure from the observation with the lowest mean arterial pressure (if mean arterial pressure has not been calculated, report the measurement with lowest systolic blood pressure). Respiratory rate: If both abnormal low and high rate observed, record the abnormally high rate. General information about ISARIC ISARIC has developed a portfolio of resources to accelerate outbreak research and response. All resources are designed to address the most critical public health questions, have undergone extensive review by international clinical experts, and are free to use. ISARIC should be acknowledged and informed if you implement the protocol. Ethical apporval of the protocol and all necessary operational and financial arrangements are the responsibility of the investigators. This form refers to the CoV CASE RECORD FORM Version 1.3 25 Aug 2020. See https://isaric.tghn.org/COVID-19-CRF/
Link
https://isaric.tghn.org/COVID-19-CRF/
Keywords
Versions (2)
- 1/18/21 1/18/21 -
- 9/20/21 9/20/21 -
Copyright Holder
ISARIC on behalf of Oxford University
Uploaded on
September 20, 2021
DOI
To request one please log in.
License
Creative Commons BY-SA 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
ISARIC/WHO Novel Coronavirus (nCoV) / COVID-19 Case Record Form
MODULE 3: OUTCOME CASE REPORT FORM
- StudyEvent: ODMjoin
Description
At ANY time during hospitalisation, did the patient receive/undergo:
Alias
- UMLS CUI-1
- C0087111
Description
Complete this field for all patients. If the patient received any form of supplementary oxygen, via nose cannula, mask or non-invasive or invasive ventilation tick ‘yes’ and indicate the total days they received any form of oxygen (O2) therapy. If any supplemental oxygen (at any concentration) was given by any means of delivery at any point during the patient’s hospital stay, place a cross in the box marked ‘yes’. This includes any supplementary oxygen (O2) delivered via non-invasive facemasks/nasal cannula/mask or via invasive mechanical ventilation. Please also indicate the maximum O2 flow volume. If it is not possible to access record of the absolute highest O2 volume delivered during the admission indicate the highest known.
Data type
integer
Alias
- UMLS CUI [1]
- C0184633
Description
Complete this field for all patients. If the patient received any form of supplementary oxygen, via nose cannula, mask or non-invasive or invasive ventilation tick ‘yes’ and indicate the total days they received any form of oxygen (O2) therapy. If any supplemental oxygen (at any concentration) was given by any means of delivery at any point during the patient’s hospital stay, place a cross in the box marked ‘yes’. This includes any supplementary oxygen (O2) delivered via non-invasive facemasks/nasal cannula/mask or via invasive mechanical ventilation. Please also indicate the maximum O2 flow volume. If it is not possible to access record of the absolute highest O2 volume delivered during the admission indicate the highest known. For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.
Data type
integer
Measurement units
- days
Alias
- UMLS CUI [1,1]
- C0184633
- UMLS CUI [1,2]
- C0449238
- UMLS CUI [1,3]
- C2348235
Description
Complete this field for all patients. If the patient received any form of supplementary oxygen, via nose cannula, mask or non-invasive or invasive ventilation tick ‘yes’ and indicate the total days they received any form of oxygen (O2) therapy. If any supplemental oxygen (at any concentration) was given by any means of delivery at any point during the patient’s hospital stay, place a cross in the box marked ‘yes’. This includes any supplementary oxygen (O2) delivered via non-invasive facemasks/nasal cannula/mask or via invasive mechanical ventilation. Please also indicate the maximum O2 flow volume. If it is not possible to access record of the absolute highest O2 volume delivered during the admission indicate the highest known.
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0184633
- UMLS CUI [1,2]
- C0449238
- UMLS CUI [1,3]
- C0439673
Description
Maximum O2 flow volume
Data type
integer
Alias
- UMLS CUI [1]
- C1960999
Description
If the patient received non-invasive ventilation (NIV), defined as the provision of ventilatory support through the patient's upper airway using a mask or similar device, at any time during their hospital stay, place tick ‘yes’ and enter the total duration in days if known.
Data type
integer
Alias
- UMLS CUI [1]
- C1997883
Description
If the patient received non-invasive ventilation (NIV), defined as the provision of ventilatory support through the patient's upper airway using a mask or similar device, at any time during their hospital stay, place tick ‘yes’ and enter the total duration in days if known. For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.
Data type
integer
Measurement units
- days
Alias
- UMLS CUI [1,1]
- C1997883
- UMLS CUI [1,2]
- C0449238
- UMLS CUI [1,3]
- C2348235
Description
If the patient received non-invasive ventilation (NIV), defined as the provision of ventilatory support through the patient's upper airway using a mask or similar device, at any time during their hospital stay, place tick ‘yes’ and enter the total duration in days if known.
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1997883
- UMLS CUI [1,2]
- C0449238
- UMLS CUI [1,3]
- C0439673
Description
Invasive ventilation means that patient has undergone tracheal intubation, for the purpose of invasive mechanical ventilation. Invasive ventilation is a method to mechanically assist or replace spontaneous breathing in patients by use of a powered device that forces oxygenated air into the lungs. The mode of intubation may be orotracheal, nasotracheal, or via a cricothyrotomy or tracheotomy.
Data type
integer
Alias
- UMLS CUI [1]
- C1868981
Description
For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.
Data type
integer
Measurement units
- days
Alias
- UMLS CUI [1,1]
- C1868981
- UMLS CUI [1,2]
- C0449238
Description
Invasive ventilation means that patient has undergone tracheal intubation, for the purpose of invasive mechanical ventilation. Invasive ventilation is a method to mechanically assist or replace spontaneous breathing in patients by use of a powered device that forces oxygenated air into the lungs. The mode of intubation may be orotracheal, nasotracheal, or via a cricothyrotomy or tracheotomy.
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1868981
- UMLS CUI [1,2]
- C0439673
Description
Prone ventilation refers to ventilation with the patient lying in the prone position. If the patient received prone ventilation at any time during their hospital stay, please tick ‘yes’ and indicate the total duration in days.
Data type
integer
Alias
- UMLS CUI [1,1]
- C0808387
- UMLS CUI [1,2]
- C0033422
Description
Prone ventilation refers to ventilation with the patient lying in the prone position. If the patient received prone ventilation at any time during their hospital stay, please tick ‘yes’ and indicate the total duration in days. For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.
Data type
integer
Measurement units
- days
Alias
- UMLS CUI [1,1]
- C0808387
- UMLS CUI [1,2]
- C0033422
- UMLS CUI [1,3]
- C0449238
- UMLS CUI [1,4]
- C2348235
Description
Prone ventilation refers to ventilation with the patient lying in the prone position. If the patient received prone ventilation at any time during their hospital stay, please tick ‘yes’ and indicate the total duration in days.
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0808387
- UMLS CUI [1,2]
- C0033422
- UMLS CUI [1,3]
- C0449238
- UMLS CUI [1,4]
- C0439673
Description
If the patient received inhaled nitric oxide at any time during their hospital stay, place a cross (X) in the box marked ‘yes’. If they did not, place a cross in the box marked ‘no’. If the answer is not known, place a cross in the box marked ‘N/A’.
Data type
integer
Alias
- UMLS CUI [1]
- C1135443
Description
If the patient received a tracheostomy, place a cross (X) in the box marked ‘yes’. If they did not, place a cross in the box marked ‘no’. If the answer is not known, place a cross in the box marked ‘N/A’.
Data type
integer
Alias
- UMLS CUI [1]
- C0040590
Description
Extracorporeal Life Support (ECLS), also known as Extracorporeal membrane oxygenation (ECMO) is a variation of cardiopulmonary bypass, it maintains tissue oxygenation for days to weeks in patients with life threatening respiratory or cardiac failure (or both). N/A’).
Data type
integer
Alias
- UMLS CUI [1]
- C4068956
Description
Extracorporeal Life Support (ECLS), also known as Extracorporeal membrane oxygenation (ECMO) is a variation of cardiopulmonary bypass, it maintains tissue oxygenation for days to weeks in patients with life threatening respiratory or cardiac failure (or both). N/A’). For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.
Data type
integer
Measurement units
- days
Alias
- UMLS CUI [1,1]
- C4068956
- UMLS CUI [1,2]
- C0449238
- UMLS CUI [1,3]
- C2348235
Description
Extracorporeal Life Support (ECLS), also known as Extracorporeal membrane oxygenation (ECMO) is a variation of cardiopulmonary bypass, it maintains tissue oxygenation for days to weeks in patients with life threatening respiratory or cardiac failure (or both). N/A’).
Data type
boolean
Alias
- UMLS CUI [1,1]
- C4068956
- UMLS CUI [1,2]
- C0439673
Description
Renal replacement therapy includes haemodialysis, peritoneal dialysis (PD), intermittent haemodialysis (IHD), on-line intermittent haemofiltration (IHF), on-line haemodiafiltration (IHDF), continuous haemofiltration (CHF) and continuous haemodiafiltration (CHDF), continuous venovenous haemofiltration (CVVH), continuous venovenous haemodialysis (CVVHD), continuous venovenous haemodiafiltration (CVVHDF), slow continuous ultrafiltration (SCUF), continuous arteriovenous haemofiltration (CAVHD) and sustained low- efficiency dialysis (SLED).
Data type
integer
Alias
- UMLS CUI [1]
- C0206074
- UMLS CUI [2]
- C0011946
Description
A vasopressor is a pharmaceutical agent that causes vasoconstriction. Agents include norepinephrine, epinephrine, vasopressin, terlipressin and phenylephrine. An inotrope is a pharmaceutical agent that alters the force of myocardial contractility. Commonly used ‘positive’ inotropes include dobutamine, dopamine, milrinone and adrenaline (epinephrine). If the patient received a vasopressor or inotrope for at least one hour during their hospital stay, place tick ‘yes’ and the total duration in days if known.
Data type
integer
Alias
- UMLS CUI [1]
- C0304509
- UMLS CUI [2]
- C0042397
Description
A vasopressor is a pharmaceutical agent that causes vasoconstriction. Agents include norepinephrine, epinephrine, vasopressin, terlipressin and phenylephrine. An inotrope is a pharmaceutical agent that alters the force of myocardial contractility. Commonly used ‘positive’ inotropes include dobutamine, dopamine, milrinone and adrenaline (epinephrine). If the patient received a vasopressor or inotrope for at least one hour during their hospital stay, place tick ‘yes’ and the total duration in days if known. For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.
Data type
integer
Measurement units
- days
Alias
- UMLS CUI [1,1]
- C0042397
- UMLS CUI [1,2]
- C0449238
- UMLS CUI [1,3]
- C2348235
- UMLS CUI [2,1]
- C0304509
- UMLS CUI [2,2]
- C0449238
- UMLS CUI [2,3]
- C2348235
Description
A vasopressor is a pharmaceutical agent that causes vasoconstriction. Agents include norepinephrine, epinephrine, vasopressin, terlipressin and phenylephrine. An inotrope is a pharmaceutical agent that alters the force of myocardial contractility. Commonly used ‘positive’ inotropes include dobutamine, dopamine, milrinone and adrenaline (epinephrine). If the patient received a vasopressor or inotrope for at least one hour during their hospital stay, place tick ‘yes’ and the total duration in days if known.
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0304509
- UMLS CUI [1,2]
- C0439673
- UMLS CUI [2,1]
- C0042397
- UMLS CUI [2,2]
- C0439673
Description
Place a cross (X) in the appropriate box: yes, (if admitted) or no (if this is not the case).
Data type
integer
Alias
- UMLS CUI [1]
- C0583239
- UMLS CUI [2]
- C1301858
Description
Please enter the total number of days the patient was admitted to the ICU/HDU, this should include all ICU/HDU admissions if there were more than one. Count any day in which the patient was in ICU/HDU during that 24 hour period (please note this number could be significantly shorter than indicated by the two dates indicated in the first and last day field if the patient was discharged to another ward/unit and readmitted to the ICU/HDU during their hospital stay). For all questions of duration, please count the number of calendar days that the patient received the treatment. For treatments that were stopped and restarted, count those days on which the treatment was given but don’t count any calendar days on which it was not given at all.
Data type
integer
Measurement units
- days
Alias
- UMLS CUI [1,1]
- C1627345
- UMLS CUI [1,2]
- C0444921
- UMLS CUI [1,3]
- C2348235
- UMLS CUI [2,1]
- C0021708
- UMLS CUI [2,2]
- C0444921
- UMLS CUI [2,3]
- C2348235
Description
Please enter the total number of days the patient was admitted to the ICU/HDU, this should include all ICU/HDU admissions if there were more than one. Count any day in which the patient was in ICU/HDU during that 24 hour period (please note this number could be significantly shorter than indicated by the two dates indicated in the first and last day field if the patient was discharged to another ward/unit and readmitted to the ICU/HDU during their hospital stay).
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1627345
- UMLS CUI [1,2]
- C0449238
- UMLS CUI [1,3]
- C0439673
- UMLS CUI [2,1]
- C0021708
- UMLS CUI [2,2]
- C0449238
- UMLS CUI [2,3]
- C0439673
Description
Date of most recent admission from ICU/ HDU. This section may need to be revised if the patient has more than one ICU/HDU admission during a single hospital admission.
Data type
date
Alias
- UMLS CUI [1,1]
- C0583239
- UMLS CUI [1,2]
- C1302393
- UMLS CUI [2,1]
- C1301858
- UMLS CUI [2,2]
- C1302393
Description
If the answer is YES, please indicate the date on which the patient was first admitted to the intensive care unit / High Dependence Unit (ICU/HDU).
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0583239
- UMLS CUI [1,2]
- C1302393
- UMLS CUI [1,3]
- C0439673
- UMLS CUI [2,1]
- C1301858
- UMLS CUI [2,2]
- C1302393
- UMLS CUI [2,3]
- C0439673
Description
Date of most recent discharge from ICU/ HDU. This section may need to be revised if the patient has more than one ICU/HDU admission during a single hospital admission.
Data type
date
Alias
- UMLS CUI [1,1]
- C1627345
- UMLS CUI [1,2]
- C2361123
- UMLS CUI [2,1]
- C0021708
- UMLS CUI [2,2]
- C2361123
Description
Date of most recent discharge from ICU/ HDU. This section may need to be revised if the patient has more than one ICU/HDU admission during a single hospital admission.
Data type
date
Alias
- UMLS CUI [1,1]
- C1627345
- UMLS CUI [1,2]
- C2361123
- UMLS CUI [1,3]
- C0439673
- UMLS CUI [2,1]
- C0021708
- UMLS CUI [2,2]
- C2361123
- UMLS CUI [2,3]
- C0439673
Description
At any time during hospitalisation did the patient experience
Alias
- UMLS CUI-1
- C0009566
Description
Clinically or radiologically diagnosed viral pneumonitis/pneumonia. For all items in this group: Please select all that were clinically identified at any time during the hospital admission. Do not include known comorbidities (e.g. previous atrial fibrillation should not be included but new onset during this admission should). Record physician diagnosed complications.
Data type
integer
Alias
- UMLS CUI [1]
- C0032310
Description
Clinically or radiologically diagnosed bacterial pneumonia (including community, hospital and ventilator acquired) managed with antimicrobials. Bacteriological confirmation not required.
Data type
integer
Alias
- UMLS CUI [1]
- C0004626
Description
Defined according to Berlin criteria as: - Occurring within 1 week of a known clinical insult or worsening respiratory symptoms - Bilateral radiological opacities not fully explained by effusions, lobar/lung collapse, or nodules - Respiratory failure not fully explained by cardiac failure or fluid overload
Data type
integer
Alias
- UMLS CUI [1]
- C4534309
Description
Defined according to Berlin criteria as: - Occurring within 1 week of a known clinical insult or worsening respiratory symptoms - Bilateral radiological opacities not fully explained by effusions, lobar/lung collapse, or nodules - Respiratory failure not fully explained by cardiac failure or fluid overload The severity of the hypoxaemia defines the severity of the ARDS: Mild ARDS: The PaO2/FiO2 is >200 mmHg, but ≤300 mmHg, on ventilator settings that include positive end- expiratory pressure (PEEP) or continuous positive airway pressure (CPAP) ≥5 cm H2O. Moderate ARDS: The PaO2/FiO2 is >100 mmHg, but ≤200 mmHg, on ventilator settings that include PEEP ≥5 cm H2O. Severe ARDS: The PaO2/FiO2 is ≤100 mmHg on ventilators setting that include PEEP ≥5 cm H2O. To determine the PaO2/FiO2 ratio, the PaO2 is measured in mmHg and the FiO2 is expressed as a decimal between 0.21 and 1. As an example, if a patient has a PaO2 of 60 mmHg while receiving 60% oxygen, then the PaO2/FiO2 is 60/0.6 = 100 mmHg.
Data type
integer
Alias
- UMLS CUI [1,1]
- C4534309
- UMLS CUI [1,2]
- C0439793
Description
Is defined as the abnormal presence of air in the pleural cavity (between the lungs and the chest wall), causing collapse of the lung. It may be diagnosed clinically, usually with radiological confirmation.
Data type
integer
Alias
- UMLS CUI [1]
- C0032326
Description
Is defined as increased amounts of fluid within the pleural cavity. It may be diagnosed clinically, with or without radiological or interventional confirmation.
Data type
integer
Alias
- UMLS CUI [1]
- C1253943
Description
Idiopathic diffuse interstitial lung disease, diagnosed radiologically (multiple consolidative or ground glass opacities) or histologically (granulation tissue and chronic inflammatory infiltrate in alveoli). Formerly known as bronchiolitis obliterans organizing pneumonia (BOOP)
Data type
integer
Alias
- UMLS CUI [1]
- C0242770
Description
This is a clinical diagnosis.
Data type
integer
Alias
- UMLS CUI [1]
- C0006271
Description
Sudden cessation of cardiac activity with no normal breathing and no signs of circulation.
Data type
integer
Alias
- UMLS CUI [1]
- C0018790
Description
Myocardial ischaemia (MI) leading to injury/necrosis, diagnosed by clinical findings, altered electrocardiography and elevated cardiac enzymes.
Data type
integer
Alias
- UMLS CUI [1]
- C0027051
Description
Is defined as diminished blood and oxygen supply to the heart muscle, also known as myocardial ischemia, It is confirmed by an electrocardiogram (showing ischaemic changes, e.g. ST depression or elevation) and/or cardiac enzyme elevation.
Data type
integer
Alias
- UMLS CUI [1]
- C0151744
Description
If a cardiac arrhythmia is identified and there is no previous record of it, select ‘yes’.
Data type
integer
Alias
- UMLS CUI [1]
- C0003811
Description
Myocarditis / pericarditis refers to an inflammation of the heart or pericardium (outer lining of the heart). Diagnosis can be clinical, biochemical (cardiac enzymes) or radiological.
Data type
integer
Alias
- UMLS CUI [1]
- C0027059
- UMLS CUI [2]
- C0031046
Description
Endocarditis is an inflammation of the endocardium (inner lining of the heart). Diagnosis is according to modified Duke criteria, using evidence from microbiological results, echocardiogram and clinical signs.
Data type
integer
Alias
- UMLS CUI [1]
- C0014118
Description
Structural and functional disorders of myocardium commonly diagnosed by echocardiography. Can be primary (genetic) or secondary (e.g. following myocardial infarction).
Data type
integer
Alias
- UMLS CUI [1]
- C0878544
Description
Is defined as failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and oedema.
Data type
integer
Alias
- UMLS CUI [1]
- C0018802
Description
Select ‘yes’ for any seizure regardless of cause (e.g. febrile or due to epilepsy)
Data type
integer
Alias
- UMLS CUI [1]
- C0036572
Description
Stroke may be a clinical diagnosis, with or without supportive radiological findings.
Data type
integer
Alias
- UMLS CUI [1]
- C0038454
Description
Inflammation of the meninges or the brain parenchyma. Select yes if diagnosed clinically, radiologically or microbiologically.
Data type
integer
Alias
- UMLS CUI [1]
- C0497299
Description
Growth of bacteria on a blood culture. Select ‘no’ if the only bacteria grown were believed to be skin contaminants (e.g. coagulase negative Staphylococci or diphtheroids).
Data type
integer
Alias
- UMLS CUI [1]
- C0004610
Description
Abnormal coagulation identified by abnormal prothrombin time or activated partial thromboplastin time. Disseminated intravascular coagulation (DIC; consumption coagulopathy; defibrination syndrome) is defined by thrombocytopenia, prolonged prothrombin time, low fibrinogen, elevated D-dimer and thrombotic microangiopathy.
Data type
integer
Alias
- UMLS CUI [1]
- C0012739
- UMLS CUI [2]
- C0005779
Description
Obstruction of pulmonary artery by thrombus, air or fat. Physician diagnosis based on clinical signs, computed tomographic pulmonary angiography and/or ventilation/perfusion scanning.
Data type
integer
Alias
- UMLS CUI [1]
- C0034065
Description
Select ‘yes’ if haemoglobin levels were lower than age- and sex-specific thresholds listed in https://media.tghn.org/medialibrary/2020/04/ISARIC_nCoV_CRF_Completion_Guide_V1.3_24Feb2020.pdf (Page 15 of 22)
Data type
integer
Alias
- UMLS CUI [1]
- C0002871
Description
Rhabdomyolysis is a syndrome characterised by muscle necrosis and the release of myoglobin into the blood. Muscle biopsy, electromyography, radiological imaging and the presence of myoglobinuria are not required for the diagnosis. Myositis may be a clinical diagnosis with supporting evidence from laboratory tests e.g. elevated serum creatine kinase; histological confirmation is not required to make the diagnosis. Myositis can occur without progression to rhabdomyolysis.
Data type
integer
Alias
- UMLS CUI [1]
- C0035410
- UMLS CUI [2]
- C0027121
Description
Acute renal injury is defined as any of: - Increase in serum creatinine by ≥0.3 mg/dL (≥26.5 μmol/L) within 48 hours - Increase in serum creatinine to ≥1.5 times baseline, which is known or presumed to have occurred within the prior 7 days - Urine volume <0.5 mL/kg/hour for 6 hours
Data type
integer
Alias
- UMLS CUI [1]
- C0022660
- UMLS CUI [2]
- C2609414
Description
Refers to bleeding originating from any part of the gastrointestinal tract (from the oropharynx to the rectum).
Data type
integer
Alias
- UMLS CUI [1]
- C0017181
Description
Inflammation of the pancreas, diagnosed from clinical, biochemical, radiological or histological evidence.
Data type
integer
Alias
- UMLS CUI [1]
- C0030305
Description
A finding that indicates abnormal liver function, may refer to any of the following: - Clinical jaundice - Hyperbilirubinaemia (blood bilirubin level twice the upper limit of the normal range) - An increase in alanine transaminase or aspartate transaminase that is twice the upper limit of the normal range
Data type
integer
Alias
- UMLS CUI [1]
- C0086565
Description
For adults, is defined as an abnormally high level of glucose in the blood, blood glucose level that is consistently above 126mg/dL or 7 mmol/L. For children, is defined as a blood glucose level consistently above 8.3 mmol/L.
Data type
integer
Alias
- UMLS CUI [1]
- C0020456
Description
For adults, is defined as an abnormally low level of glucose in the blood, a blood glucose level that is consistently below 70mg/dL or 4 mmol/L. For children, is defined as a blood glucose level below 3 mmol/L.
Data type
integer
Alias
- UMLS CUI [1]
- C0020615
Description
Please specify other complications in the space provided.
Data type
integer
Alias
- UMLS CUI [1,1]
- C0009566
- UMLS CUI [1,2]
- C0205394
Description
Other Complications Specification
Data type
text
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C0009566
- UMLS CUI [1,3]
- C2348235
Description
Diagnostics
Alias
- UMLS CUI-1
- C0430022
Description
Please record if the patient was clinically diagnosed with COVID-19, even if resources did not allow testing or if laboratory results were negative but the clinician judged that based on symptoms, onset and clinical case definitions COVID-19 infection was the most likely cause of the symptoms experienced. Please complete all of the Diagnostics section even if results were negative, to monitor co-infection risk and rates.
Data type
integer
Alias
- UMLS CUI [1,1]
- C5203670
- UMLS CUI [1,2]
- C0332140
Description
If laboratory testing was done, complete the section Select YES – Confirmed if the test was positive, Yes – Probable if there was a clinical diagnosis but no positive lab test and NO if the lab test was negative. If the lab test was not done or there is no clinical diagnosis please leave blank.
Data type
integer
Alias
- UMLS CUI [1,1]
- C0450254
- UMLS CUI [1,2]
- C0022885
- UMLS CUI [1,3]
- C0347984
- UMLS CUI [1,4]
- C0012634
- UMLS CUI [1,5]
- C1948053
Description
If patient diagnosed with COVID-19 either confirmed or probable per definition above mark an 'X' in the box for Novel CoV.
Data type
integer
Alias
- UMLS CUI [1]
- C0206422
Description
If patient diagnosed with COVID-19 either confirmed or probable per definition above mark an 'X' in the box for Novel CoV.
Data type
integer
Alias
- UMLS CUI [1,1]
- C0206422
- UMLS CUI [1,2]
- C0449560
Description
Other Coronavirus Subtype
Data type
text
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C0206422
- UMLS CUI [1,3]
- C0449560
- UMLS CUI [1,4]
- C2348235
Description
Influenza
Data type
integer
Alias
- UMLS CUI [1]
- C0021400
Description
Influenza subtype
Data type
integer
Alias
- UMLS CUI [1,1]
- C0021400
- UMLS CUI [1,2]
- C0449560
Description
Other Influenza subtype
Data type
text
Alias
- UMLS CUI [1,1]
- C0021400
- UMLS CUI [1,2]
- C0449560
- UMLS CUI [1,3]
- C2348235
Description
RSV
Data type
integer
Alias
- UMLS CUI [1]
- C0035236
Description
Adenovirus
Data type
integer
Alias
- UMLS CUI [1]
- C0001483
Description
Bacteria
Data type
integer
Alias
- UMLS CUI [1]
- C0004611
Description
Bacteria specification
Data type
text
Alias
- UMLS CUI [1,1]
- C0004611
- UMLS CUI [1,2]
- C2348235
- UMLS CUI [1,3]
- C0370003
Description
Bacteria specimen unknown
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0004611
- UMLS CUI [1,2]
- C2348235
- UMLS CUI [1,3]
- C0439673
Description
Other pathogen/s detected
Data type
integer
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C0450254
- UMLS CUI [1,3]
- C0243095
Description
Other pathogen/s detected - specification
Data type
text
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C0450254
- UMLS CUI [1,3]
- C2348235
Description
Other pathogen/s detected - specimen unknown
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C0450254
- UMLS CUI [1,3]
- C0370003
- UMLS CUI [1,4]
- C0439673
Description
Tick ‘yes’ f this was a Physician diagnosis.
Data type
integer
Alias
- UMLS CUI [1]
- C0543829
Description
Record if X-ray and/or CT were performed, even if no infiltrates were present.
Data type
integer
Alias
- UMLS CUI [1,1]
- C0039985
- UMLS CUI [1,2]
- C0884358
Description
Chest X-Ray: infiltrates present
Data type
integer
Alias
- UMLS CUI [1]
- C2073654
Description
Record if X-ray and/or CT were performed, even if no infiltrates were present.
Data type
integer
Alias
- UMLS CUI [1,1]
- C0040405
- UMLS CUI [1,2]
- C0884358
Description
CT performed: infiltrates present
Data type
integer
Alias
- UMLS CUI [1]
- C2073654
Description
Biospecimen Testing
Alias
- UMLS CUI-1
- C2347026
- UMLS CUI-2
- C0022885
Description
Collection Date
Data type
date
Alias
- UMLS CUI [1]
- C1302413
Description
If the patient had samples taken for pathogen detection testing during their hospital stay, please complete a row for every type of sample collected (e.g. nasal/NP swab, sputum, etc.). Where both positive and negative results for a particular sample type exist (from samples taken at different time points during the patient’s hospital stay) please record the earliest positive result. If only multiple negative results exist for a particular sample type (from samples taken at different time points during the patient’s hospital stay), please document the earliest negative result.
Data type
text
Alias
- UMLS CUI [1]
- C2347029
Description
Other Biospecimen Type
Data type
text
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C2347029
- UMLS CUI [1,3]
- C2348235
Description
Laboratory test Method
Data type
integer
Alias
- UMLS CUI [1]
- C2826902
Description
Other laboratory test method
Data type
text
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C2826902
- UMLS CUI [1,3]
- C2348235
Description
Laboratory Test Result
Data type
integer
Alias
- UMLS CUI [1]
- C0587081
Description
Pathogen Tested/Detected
Data type
text
Alias
- UMLS CUI [1,1]
- C0450254
- UMLS CUI [1,2]
- C1511790
Description
Medication: While hospitalised or at discharge, were any of the following administered? Antiviral therapy
Alias
- UMLS CUI-1
- C0280274
Description
Record all antivirals administered from date of admission or during the hospitalisation. Record the total number of days the treatment was given. For other antiviral or COVID-19 targeted agents record any medications given to treat COVID-19 that are not already pre-specified elsewhere in this section. Additional space is available under ‘Other treatments...’ at the end of this section if required.
Data type
integer
Alias
- UMLS CUI [1]
- C0003451
- UMLS CUI [2,1]
- C5203670
- UMLS CUI [2,2]
- C2985566
Description
Antiviral agents administered
Data type
integer
Alias
- UMLS CUI [1,1]
- C0003451
- UMLS CUI [1,2]
- C2348235
- UMLS CUI [2,1]
- C5203670
- UMLS CUI [2,2]
- C2985566
- UMLS CUI [2,3]
- C2348235
Description
Other Antiviral agent
Data type
text
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C0003451
Description
Antiviral agent - Start date
Data type
date
Alias
- UMLS CUI [1,1]
- C0003451
- UMLS CUI [1,2]
- C0808070
Description
‘Antiviral Agent’ refers to any agent(s) prescribed to treat or prevent viral infections by interfering with the viral replication cycle. If the patient received antivirals at any time during their hospital stay, place a cross in the box marked ‘yes’ and also indicate the type of antiviral agent.
Data type
integer
Measurement units
- days
Alias
- UMLS CUI [1,1]
- C0003451
- UMLS CUI [1,2]
- C0449238
Description
Antiviral treatment duration unknown
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0003451
- UMLS CUI [1,2]
- C0449238
- UMLS CUI [1,3]
- C0439673
Description
Medication: While hospitalised or at discharge, were any of the following administered? Antibiotic therapy
Alias
- UMLS CUI-1
- C0338237
Description
‘Antibiotic’ refers to any agent(s) are substances naturally produced by microorganisms or their derivatives that selectively target microorganisms. These substances are used in the treatment of bacterial and other microbial infections. Topical preparations are not included.
Data type
integer
Alias
- UMLS CUI [1]
- C0338237
Description
‘Antibiotic’ refers to any agent(s) are substances naturally produced by microorganisms or their derivatives that selectively target microorganisms. These substances are used in the treatment of bacterial and other microbial infections. Topical preparations are not included.
Data type
text
Alias
- UMLS CUI [1]
- C0338237
Description
Antibiotic therapy - Date commenced
Data type
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0338237
Description
Antibiotic therapy - duration
Data type
integer
Measurement units
- days
Alias
- UMLS CUI [1,1]
- C0338237
- UMLS CUI [1,2]
- C0449238
Description
Antibiotic therapy duration unknown
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0338237
- UMLS CUI [1,2]
- C0449238
- UMLS CUI [1,3]
- C0439673
Description
While hospitalised or at discharge, were any of the following administered? Corticosteriods
Alias
- UMLS CUI-1
- C0001617
Description
‘Corticosteroids’ (commonly referred to as ‘steroids’) refers to all types of therapeutic corticosteroid, made in the adrenal cortex (the outer part of the adrenal gland). They are also made in the laboratory. Examples include: prednisolone, prednisone, methyl- prednisolone, dexamethasone, hydrocortisone, fluticasone, betamethasone (note that other examples exist). Topical preparations are not included, but inhaled preparations are included. The indication for administering corticosteroids does not need to be directly related to the treatment of COVID-19.
Data type
integer
Alias
- UMLS CUI [1]
- C0239126
Description
Corticosteroid: oral route of administration
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1527415
- UMLS CUI [1,2]
- C0239126
Description
Corticosteroid: intravenous route of administration
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0239126
- UMLS CUI [1,2]
- C1522726
Description
Corticosteroid: inhaled route of administration
Data type
boolean
Alias
- UMLS CUI [1]
- C0586793
Description
Corticosteroid: unknown route of administration
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0239126
- UMLS CUI [1,2]
- C1521803
Description
Oral oder IV Corticosteroid: agent
Data type
text
Alias
- UMLS CUI [1,1]
- C1527415
- UMLS CUI [1,2]
- C0149783
- UMLS CUI [1,3]
- C2348235
- UMLS CUI [2,1]
- C0149783
- UMLS CUI [2,2]
- C2348235
- UMLS CUI [2,3]
- C1621368
Description
Oral oder IV Corticosteroid: dosage and unit
Data type
text
Alias
- UMLS CUI [1,1]
- C1527415
- UMLS CUI [1,2]
- C0239126
- UMLS CUI [1,3]
- C0806909
- UMLS CUI [1,4]
- C2348070
- UMLS CUI [2,1]
- C0239126
- UMLS CUI [2,2]
- C1621368
- UMLS CUI [2,3]
- C0806909
- UMLS CUI [2,4]
- C2348070
- UMLS CUI [3,1]
- C1527415
- UMLS CUI [3,2]
- C0239126
- UMLS CUI [3,3]
- C2348328
- UMLS CUI [4,1]
- C0239126
- UMLS CUI [4,2]
- C1621368
- UMLS CUI [4,3]
- C2348328
Description
Corticosteroid - Start date
Data type
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0149783
Description
Corticosteroid - Start date unknown
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0149783
- UMLS CUI [1,3]
- C0439673
Description
Corticosteroid therapy duration
Data type
integer
Measurement units
- days
Alias
- UMLS CUI [1,1]
- C0149783
- UMLS CUI [1,2]
- C0449238
Description
Corticosteroid therapy duration unknown
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0449238
- UMLS CUI [1,2]
- C0149783
- UMLS CUI [1,3]
- C0439673
Description
Medication: While hospitalised or at discharge, were any of the following administered? Heparin
Alias
- UMLS CUI-1
- C0019134
Description
Heparin
Data type
integer
Alias
- UMLS CUI [1,1]
- C0019134
- UMLS CUI [1,2]
- C1533734
Description
Heparin - Subcutaneous route of administration
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0019134
- UMLS CUI [1,2]
- C1522438
Description
Heparin - Intravenous (IV) route of administration
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0019134
- UMLS CUI [1,2]
- C1522726
Description
Heparin - unknown route of administration
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0019134
- UMLS CUI [1,2]
- C1521803
Description
Unfractionated heparin
Data type
boolean
Alias
- UMLS CUI [1]
- C2825026
Description
Heparin type - Low molecular weight
Data type
boolean
Alias
- UMLS CUI [1]
- C0019139
Description
Fondaparinux
Data type
boolean
Alias
- UMLS CUI [1]
- C1098510
Description
Heparin type unknown
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0332307
- UMLS CUI [1,2]
- C0019134
- UMLS CUI [1,3]
- C0439673
Description
Heparin dosage and unit
Data type
text
Alias
- UMLS CUI [1,1]
- C0806909
- UMLS CUI [1,2]
- C2348070
- UMLS CUI [1,3]
- C0019134
- UMLS CUI [2,1]
- C2348328
- UMLS CUI [2,2]
- C0019134
Description
Heparin - Start date
Data type
date
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0019134
Description
Heparin - Start date unknown
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C0019134
- UMLS CUI [1,3]
- C0439673
Description
Heparin therapy duration
Data type
integer
Measurement units
- days
Alias
- UMLS CUI [1,1]
- C0449238
- UMLS CUI [1,2]
- C0019134
Description
Heparin therapy duration unknown
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0449238
- UMLS CUI [1,2]
- C0019134
- UMLS CUI [1,3]
- C0439673
Description
Medication: While hospitalised or at discharge, were any of the following administered? Antifungal therapy
Alias
- UMLS CUI-1
- C0678026
Description
‘Antifungal agent’ refers to any agent(s) prescribed specifically to treat systemic or topical infections caused by fungi. Examples include fluconazole, amphotericin, caspofungin, anidulafungin, posaconazole, itraconazole (note that other examples exist). Topical preparations should not be recorded.
Data type
integer
Alias
- UMLS CUI [1]
- C0003308
Description
Medication: While hospitalised or at discharge, were any of the following administered? Other treatments administered for COVID-19
Alias
- UMLS CUI-1
- C5203670
- UMLS CUI-2
- C0205394
- UMLS CUI-3
- C0013227
Description
Record any other medications, experimental or re-purposed, administered to modify the course of COVID-19 during the admission (including as part of a clinical trial). This could include convalescent plasma, immuno-modulatory agents and anti-viral agents not already recorded above.
Data type
integer
Alias
- UMLS CUI [1,1]
- C5203670
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C0013227
- UMLS CUI [2,1]
- C0304229
- UMLS CUI [2,2]
- C5203670
- UMLS CUI [3,1]
- C0013227
- UMLS CUI [3,2]
- C2718016
- UMLS CUI [3,3]
- C5203670
Description
Other treatments administered for COVID-19
Data type
text
Alias
- UMLS CUI [1,1]
- C5203670
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C0013227
Description
Other treatment for COVID-19: dosage and unit
Data type
text
Alias
- UMLS CUI [1,1]
- C5203670
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C0013227
- UMLS CUI [1,4]
- C0806909
- UMLS CUI [1,5]
- C2348070
- UMLS CUI [2,1]
- C5203670
- UMLS CUI [2,2]
- C0205394
- UMLS CUI [2,3]
- C0013227
- UMLS CUI [2,4]
- C2348328
Description
Other treatment for COVID-19: Date of commencement
Data type
date
Alias
- UMLS CUI [1,1]
- C5203670
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C0013227
- UMLS CUI [1,4]
- C0808070
Description
Other treatment for COVID-19: Date of commencement known
Data type
boolean
Alias
- UMLS CUI [1,1]
- C5203670
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C0013227
- UMLS CUI [1,4]
- C0808070
- UMLS CUI [1,5]
- C0439673
Description
Other treatment for COVID-19: Duration of therapy
Data type
integer
Measurement units
- days
Alias
- UMLS CUI [1,1]
- C5203670
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C0013227
- UMLS CUI [1,4]
- C0449238
Description
Other treatment for COVID-19: Duration of therapy known
Data type
boolean
Alias
- UMLS CUI [1,1]
- C5203670
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C0013227
- UMLS CUI [1,4]
- C0449238
Description
Outcome
Alias
- UMLS CUI-1
- C1547647
Description
Discharged alive can mean discharge to their usual place of residence before their illness, to the home of a relative or friend, or to a social care facility, because their illness is no longer severe enough to warrant treatment in a medical facility. Hospitalized means they are still in hospital but have recovered from COVID-19 infection and the form has been completed as the patient is in a part of the hospital for care of other conditions and where the form will not be completed at a later date. Transfer to other facility means they have been transferred to another facility that provides medical care. This could be a specialist centre for more intensive treatment or a step-down for rehabilitation. It does not include facilities that solely provide social care (these patients should be listed as discharged alive). Death means the patient died in the hospital. Palliative discharge means the patient has been discharged with the expectation that they will not recover from this or other co-existing illness. This could be to a specialist hospice facility, or to their usual home address with anticipatory end of life medications.
Data type
integer
Alias
- UMLS CUI [1]
- C1547647
Description
Please state the date for the outcome listed above.
Data type
date
Alias
- UMLS CUI [1,1]
- C1547647
- UMLS CUI [1,2]
- C0011008
Description
Please state the date for the outcome listed above.
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1547647
- UMLS CUI [1,2]
- C0011008
- UMLS CUI [1,3]
- C0439673
Description
Ability to self-care at discharge versus before illness: the patient is able to care for themselves at discharge (in terms of activities of daily living) at the same level as before they developed illness then tick ‘same as before illness’. If their ability to self-care has decreased or increased, then tick the appropriate circle (‘worse’ or ‘better’).
Data type
integer
Alias
- UMLS CUI [1,1]
- C0562734
- UMLS CUI [1,2]
- C3871203
Description
(Complete this section only if the patient is alive) Oxygen therapy includes, NIV or home ventilation (respiratory support/treatment).
Data type
integer
Alias
- UMLS CUI [1,1]
- C0586003
- UMLS CUI [1,2]
- C0687676
- UMLS CUI [1,3]
- C0184633
Similar models
MODULE 3: OUTCOME CASE REPORT FORM
- StudyEvent: ODMjoin
C0449238 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,2])
C0033422 (UMLS CUI [1,2])
C0033422 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
C0033422 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
C0439673 (UMLS CUI [1,4])
C0449238 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0439673 (UMLS CUI [1,2])
C0011946 (UMLS CUI [2])
C0042397 (UMLS CUI [2])
C0449238 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0304509 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
C2348235 (UMLS CUI [2,3])
C0439673 (UMLS CUI [1,2])
C0042397 (UMLS CUI [2,1])
C0439673 (UMLS CUI [2,2])
C1301858 (UMLS CUI [2])
C0444921 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0021708 (UMLS CUI [2,1])
C0444921 (UMLS CUI [2,2])
C2348235 (UMLS CUI [2,3])
C0449238 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0021708 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
C0439673 (UMLS CUI [2,3])
C1302393 (UMLS CUI [1,2])
C1301858 (UMLS CUI [2,1])
C1302393 (UMLS CUI [2,2])
C1302393 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C1301858 (UMLS CUI [2,1])
C1302393 (UMLS CUI [2,2])
C0439673 (UMLS CUI [2,3])
C2361123 (UMLS CUI [1,2])
C0021708 (UMLS CUI [2,1])
C2361123 (UMLS CUI [2,2])
C2361123 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0021708 (UMLS CUI [2,1])
C2361123 (UMLS CUI [2,2])
C0439673 (UMLS CUI [2,3])
C0439793 (UMLS CUI [1,2])
C0031046 (UMLS CUI [2])
C0005779 (UMLS CUI [2])
C0027121 (UMLS CUI [2])
C2609414 (UMLS CUI [2])
C0205394 (UMLS CUI [1,2])
C0009566 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0332140 (UMLS CUI [1,2])
C0022885 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C0012634 (UMLS CUI [1,4])
C1948053 (UMLS CUI [1,5])
C0449560 (UMLS CUI [1,2])
C0206422 (UMLS CUI [1,2])
C0449560 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,4])
C0449560 (UMLS CUI [1,2])
C0449560 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,2])
C0370003 (UMLS CUI [1,3])
C2348235 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0450254 (UMLS CUI [1,2])
C0243095 (UMLS CUI [1,3])
C0450254 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0450254 (UMLS CUI [1,2])
C0370003 (UMLS CUI [1,3])
C0439673 (UMLS CUI [1,4])
C0884358 (UMLS CUI [1,2])
C2347029 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C2826902 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C1511790 (UMLS CUI [1,2])
C5203670 (UMLS CUI [2,1])
C2985566 (UMLS CUI [2,2])
C2348235 (UMLS CUI [1,2])
C5203670 (UMLS CUI [2,1])
C2985566 (UMLS CUI [2,2])
C2348235 (UMLS CUI [2,3])
C0003451 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0338237 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0239126 (UMLS CUI [1,2])
C1522726 (UMLS CUI [1,2])
C1521803 (UMLS CUI [1,2])
C0149783 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
C0149783 (UMLS CUI [2,1])
C2348235 (UMLS CUI [2,2])
C1621368 (UMLS CUI [2,3])
C0239126 (UMLS CUI [1,2])
C0806909 (UMLS CUI [1,3])
C2348070 (UMLS CUI [1,4])
C0239126 (UMLS CUI [2,1])
C1621368 (UMLS CUI [2,2])
C0806909 (UMLS CUI [2,3])
C2348070 (UMLS CUI [2,4])
C1527415 (UMLS CUI [3,1])
C0239126 (UMLS CUI [3,2])
C2348328 (UMLS CUI [3,3])
C0239126 (UMLS CUI [4,1])
C1621368 (UMLS CUI [4,2])
C2348328 (UMLS CUI [4,3])
C0149783 (UMLS CUI [1,2])
C0149783 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,2])
C0149783 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C1522438 (UMLS CUI [1,2])
C1522726 (UMLS CUI [1,2])
C1521803 (UMLS CUI [1,2])
C0019134 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C2348070 (UMLS CUI [1,2])
C0019134 (UMLS CUI [1,3])
C2348328 (UMLS CUI [2,1])
C0019134 (UMLS CUI [2,2])
C0019134 (UMLS CUI [1,2])
C0019134 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0019134 (UMLS CUI [1,2])
C0019134 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0205394 (UMLS CUI-2)
C0013227 (UMLS CUI-3)
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0304229 (UMLS CUI [2,1])
C5203670 (UMLS CUI [2,2])
C0013227 (UMLS CUI [3,1])
C2718016 (UMLS CUI [3,2])
C5203670 (UMLS CUI [3,3])
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0806909 (UMLS CUI [1,4])
C2348070 (UMLS CUI [1,5])
C5203670 (UMLS CUI [2,1])
C0205394 (UMLS CUI [2,2])
C0013227 (UMLS CUI [2,3])
C2348328 (UMLS CUI [2,4])
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0808070 (UMLS CUI [1,4])
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0808070 (UMLS CUI [1,4])
C0439673 (UMLS CUI [1,5])
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,4])
C0205394 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
C0449238 (UMLS CUI [1,4])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C3871203 (UMLS CUI [1,2])
C0687676 (UMLS CUI [1,2])
C0184633 (UMLS CUI [1,3])
No comments